Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort

¹ Centre of Excellence for Health, Immunity and Infections (CHIP), Department of Infectious Diseases, Rigshospitalet, and

² Institute for Clinical Medicine, University of Copenhagen, Denmark;

³ Department of Infectious Diseases, The Alfred Hospital and Monash University, Melbourne, Australia;

⁴ Institute of Tropical Medicine, Antwerp, Belgium;

⁵ Charles University Hospital Plzen, Czech Republic;

⁶ Infektionsmedizinisches Centrum Hamburg (ICH) Study Center, Innere Medizin, Hamburg, Germany;

⁷ Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania;

⁸ University Medical Centre Ljubljana, Clinic of Infectious Diseases Ljubljana, Medical Faculty, University of Ljubljana, Slovenia;

⁹ The General Hospital of Athens “G. Gennimatas” First Department Of Medicine - Infectious Diseases Unit, Athens, Greece;

¹⁰ Division of Infectious Diseases, Cantonal Hospital St. Gallen, Switzerland

¹¹ Barts and The Royal London Hospital NHS Trust, London, United Kingdom;

¹² Odense Universitetshospital, Forskningsenheden, Denmark;

¹³ Western General Hospital, Edinburgh, United Kingdom;

¹⁴ CHU Nice Hopital de l’ Archet 1, Nice, France;

¹⁵ St. James’ Hospital, Dublin, Ireland;

¹⁶ Ospedale L. Sacco, Milan, Italy;

¹⁷ Centre Hospitalier de Luxembourg, Luxemborg;

¹⁸ Hospital Curry Cabral, Lisbon, Portugal;

¹⁹ University Hospital Zürich, Switzerland;

²⁰ Skåne University Hospital, Malmö, Sweden;

²¹ Crimean Republican AIDS Centre, Simferopol, Ukraine; and

²² Department of Infection and Population Health, University College London, UK